Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study.
Saved in:
| Title: | Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study. |
|---|---|
| Authors: | Glaros SB; Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA., Mishra SP; USF Center for Microbiome Research, Microbiomes Institute, University of South Florida Morsani College of Medicine, Tampa, FL, USA.; Department of Neurosurgery and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Jain S; USF Center for Microbiome Research, Microbiomes Institute, University of South Florida Morsani College of Medicine, Tampa, FL, USA.; Department of Neurosurgery and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Davis FS; Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA., Gabel SA; Nuclear Magnetic Resonance Group, National Institute of Environmental Health Sciences, Durham, NC, USA., Mueller GA; Nuclear Magnetic Resonance Group, National Institute of Environmental Health Sciences, Durham, NC, USA., Jarmusch AK; Metabolomics Core Facility, Inflammation, Immunity and Disease Laboratory, National Institute of Environmental Health Sciences, Durham, NC, USA., Mabundo L; Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA., Courville AB; Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA., Walter MF; Clinical Laboratory Services Core, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA., Walter PJ; Clinical Mass Spectrometry Core, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA., Overdahl KE; Metabolomics Core Facility, Inflammation, Immunity and Disease Laboratory, National Institute of Environmental Health Sciences, Durham, NC, USA., Yadav H; USF Center for Microbiome Research, Microbiomes Institute, University of South Florida Morsani College of Medicine, Tampa, FL, USA.; Department of Neurosurgery and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Chung ST; Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.; Division of Diabetes and Endocrinology, Children's National Hospital, Washington, DC, USA. |
| Source: | Gut microbes [Gut Microbes] 2025 Dec; Vol. 17 (1), pp. 2558071. Date of Electronic Publication: 2025 Sep 29. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101495343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1949-0984 (Electronic) Linking ISSN: 19490976 NLM ISO Abbreviation: Gut Microbes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1949-0984 |
|---|---|
| DOI: | 10.1080/19490976.2025.2558071 |
